FluoroPharma Medical, Inc. (FPMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Apr 29, 2025
FluoroPharma Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
---|---|---|---|---|---|---|
Period Ending | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
Cash & Equivalents | 0.02 | 0.29 | 0.25 | 1.14 | 1.3 | Upgrade
|
Trading Asset Securities | - | - | 0.04 | 0.63 | - | Upgrade
|
Cash & Short-Term Investments | 0.02 | 0.29 | 0.29 | 1.78 | 1.3 | Upgrade
|
Cash Growth | -91.50% | -0.42% | -83.57% | 36.34% | -60.06% | Upgrade
|
Prepaid Expenses | 0.02 | 0.04 | 0.02 | 0.01 | 0.05 | Upgrade
|
Other Current Assets | 0 | 0.18 | 0.13 | 0.04 | 0.03 | Upgrade
|
Total Current Assets | 0.05 | 0.51 | 0.45 | 1.83 | 1.38 | Upgrade
|
Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.04 | 0.18 | Upgrade
|
Other Intangible Assets | 0.28 | 0.32 | 0.36 | 0.05 | 0.06 | Upgrade
|
Total Assets | 0.33 | 0.84 | 0.82 | 1.92 | 1.61 | Upgrade
|
Accounts Payable | 1.41 | 1.22 | 1.06 | 0.18 | 0.14 | Upgrade
|
Accrued Expenses | 0.85 | 0.51 | 0.33 | 0.09 | 0.05 | Upgrade
|
Short-Term Debt | 5.82 | 4.35 | 2.12 | - | - | Upgrade
|
Current Unearned Revenue | 0.41 | - | - | - | - | Upgrade
|
Other Current Liabilities | 2.02 | 2.62 | 2.09 | 2.7 | 0.05 | Upgrade
|
Total Current Liabilities | 10.51 | 8.7 | 5.62 | 2.97 | 0.24 | Upgrade
|
Total Liabilities | 10.51 | 8.7 | 5.62 | 2.97 | 0.24 | Upgrade
|
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
Additional Paid-In Capital | 24.96 | 24.71 | 24.03 | 23.08 | 18.24 | Upgrade
|
Retained Earnings | -35.18 | -32.6 | -28.87 | -24.17 | -16.89 | Upgrade
|
Total Common Equity | -10.18 | -7.87 | -4.8 | -1.06 | 1.38 | Upgrade
|
Shareholders' Equity | -10.18 | -7.86 | -4.8 | -1.06 | 1.38 | Upgrade
|
Total Liabilities & Equity | 0.33 | 0.84 | 0.82 | 1.92 | 1.61 | Upgrade
|
Total Debt | 5.82 | 4.35 | 2.12 | - | - | Upgrade
|
Net Cash (Debt) | -5.8 | -4.06 | -1.83 | 1.78 | 1.3 | Upgrade
|
Net Cash Growth | - | - | - | 36.34% | -60.06% | Upgrade
|
Net Cash Per Share | -0.17 | -0.14 | -0.06 | 0.07 | 0.06 | Upgrade
|
Filing Date Shares Outstanding | 34.26 | 32.91 | 29.2 | 25.68 | 24.33 | Upgrade
|
Total Common Shares Outstanding | 34.07 | 32.91 | 29.2 | 25.68 | 24.33 | Upgrade
|
Working Capital | -10.47 | -8.19 | -5.17 | -1.14 | 1.15 | Upgrade
|
Book Value Per Share | -0.30 | -0.24 | -0.16 | -0.04 | 0.06 | Upgrade
|
Tangible Book Value | -10.46 | -8.18 | -5.16 | -1.11 | 1.32 | Upgrade
|
Tangible Book Value Per Share | -0.31 | -0.25 | -0.18 | -0.04 | 0.05 | Upgrade
|
Machinery | 0.19 | 0.19 | 0.18 | 0.17 | 0.3 | Upgrade
|
Leasehold Improvements | - | - | - | 0.03 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.